Clinical Assessment of an in-Patient Glucose Monitoring System (Accu-Chek Inform Cobas IT 1000)
COBAS
Evaluation of the Implementation of the Accu-Chek Inform Cobas IT 1000 System in Three Medical Hospital Departments: Impact on the Management of Diabetes
1 other identifier
observational
949
1 country
1
Brief Summary
The principal objective of this single-center 2-period study is to evaluate the glycemic control of in-patients in 3 hospital departments (Diabetology, Cardiology and Pulmonary Care) as the rate of capillary blood glucose measurements within a pre-define target range, and to compare results during the period I (warning of the Accu-Check Inform glucose meter on glucose levels not activated) and period II (warning activated).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 14, 2007
CompletedFirst Posted
Study publicly available on registry
June 15, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedMarch 4, 2008
February 1, 2008
6 months
June 14, 2007
February 26, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
compare glycemic control of patients hospitalized in 3 departments
hospitalisation period
Secondary Outcomes (4)
number of glycemia controls
hospitalisation period
number of traceable glycemia readings
hospitalisation period
number of hypoglycemia events and frequency of measures taken
hospitalisation period
mean of % of glycemia for patients in warning phase with or without diabetologist intervention
hospitalisation period
Study Arms (2)
1
period I (warning of the Accu-Check Inform glucose meter on glucose levels not activated)
2
period II (warning activated).
Interventions
period II (warning activated)
Eligibility Criteria
Patients requiring a monitoring of capillary blood glucose levels
You may qualify if:
- In-patients,
- Age \> 18 years,
- Requiring a monitoring of capillary blood glucose levels
You may not qualify if:
- No glucose monitoring needed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Grenoblelead
- Roche Diagnostics Meylan Francecollaborator
- Assistance Medico-Technique A Domicilecollaborator
Study Sites (1)
University Hospital of Grenoble
Grenoble, 38000, France
Related Publications (7)
Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 Mar 10;352(10):969-77. doi: 10.1056/NEJMoa041533.
PMID: 15758007BACKGROUNDACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care. 2006 Aug;29(8):1955-62. doi: 10.2337/dc06-9913. No abstract available.
PMID: 16873812BACKGROUNDInzucchi SE, Rosenstock J. Counterpoint: Inpatient glucose management: a premature call to arms? Diabetes Care. 2005 Apr;28(4):976-9. doi: 10.2337/diacare.28.4.976. No abstract available.
PMID: 15793210BACKGROUNDClement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004 Feb;27(2):553-91. doi: 10.2337/diacare.27.2.553. No abstract available.
PMID: 14747243BACKGROUNDHalimi S. [Benefits of blood glucose self-monitoring in the management of insulin-dependent (IDDM) and non-insulin-dependent diabetes (NIDDM). Analysis of the literature: mixed results]. Diabetes Metab. 1998 Nov;24 Suppl 3:35-41. French.
PMID: 9881230BACKGROUNDKing H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414-31. doi: 10.2337/diacare.21.9.1414.
PMID: 9727886BACKGROUNDMise en place et conduite en France d'essais cliniques portant sur des dispositifs médicaux et dispositifs médicaux de diagnostic in vitro.Afssaps September 2006, 15. http://agmed.sante.gouv.fr
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
NELLY WION, MD
University Hospital, Grenoble
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 14, 2007
First Posted
June 15, 2007
Study Start
January 1, 2007
Primary Completion
July 1, 2007
Study Completion
January 1, 2008
Last Updated
March 4, 2008
Record last verified: 2008-02